Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Gregory A. Wiseman, Christine A. White, Richard B. Sparks, William D. Erwin, Donald A. Podoloff, Dominick Lamonica, Nancy L. Bartlett, J. Anthony Parker, William L. Dunn, Stewart M. Spies, Richard Belanger, Thomas E. Witzig, Bryan R. Leigh

Research output: Contribution to journalArticlepeer-review

165 Scopus citations

Fingerprint

Dive into the research topics of 'Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science